vimarsana.com
Home
Live Updates
Indoco Remedies shares gain on final USFDA approval for Pregabalin capsules : vimarsana.com
Indoco Remedies shares gain on final USFDA approval for Pregabalin capsules
The share touched a 52-week high of Rs 416.95 and a 52-week low of Rs 308.80 on January 1, 2024, and October 26, 2023, respectively.
Related Keywords
India ,
Aditi Panandikar ,
Drug Administration ,
Abbreviated New Drug Application ,
Indoco Remedies ,
Reference Listed Drug ,
Verna Industrial Area ,
vimarsana.com © 2020. All Rights Reserved.